Clinical Trial Update: Autologous Transplantation of Expanded Pancreatic Islet Cells (YD01-2022) in Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous transplantation of expanded pancreatic islet cells for diabetes after total pancreatectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes After Total Pancreatectomy

Drugs mentioned

• Autologous transplantation of expanded pancreatic islet cells (YD01-2022)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Diabetes After Total Pancreatectomy | Phase 2 | Status: UNKNOWN